La cytogénétique constitue un outil indispensable pour le diagnostic et le pronostic de la
leucémie aigue myéloïde (LAM). La t (8; 16)(p11; p13) est rare au cours de cette pathologie …

Les leucémies aiguës sont définies par un nombre de blastes médullaires supérieur à 20%.
Nous rapportons le cas d'une leucémie aiguë myéloïde dont le diagnostic cytologique est …

L a leucemie aigue promyelocytaire (LAP) constitue une entite dans le groupe des
leucemies aigues myelo'l'des (LAM). Les patients avec une LAP presentent des …

A 29-year-old woman having acute myelogeneous leukemia-M1 subtype with the
chromosomal abnormality t (16; 21)(p11; q22) is presented. Complete blood count at onset …

Introduction The transformation of acute myeloid leukemia with translocation (16; 16)(p13;
q22) from AML M2 to acute monocytic leukemia (AML M5) during therapy is a rare clinical …

The cellular and molecular genetic aberrations of hematopoietic and lymphoid tissues are
increasingly important in leukemia classification and are prognostically significant. Although …

Abstract The chromosome aberration t (7; 11)(p15; p15) is uncommon but recurrent in
leukemia. We experienced a case of acute leukemia with t (7; 11)(p15; p15), the …

The classification of acute myeloid leukemia (AML) recognizes a subgroup of diseases with
recurring genetic abnormalities. Translocation (15; 17) is the marker of acute promyelocitic …

Cytogenetic abnormalities play an important role in diagnosis, classification and prognosis
in acute myeloid leukemia (AML). Nevertheless, several chromosome abnormalities have …

Acute myeloid leukemia (AML) with t (8; 16)(p11; q13) is a distinct clinical and morphological
entity with poor prognosis, which is characterized by a high frequency of extramedullary …